clarus_final_indentity.jpg
Clarus Therapeutics and McGill University Announce Exclusive Worldwide Licensing Agreement To Develop and Commercialize Technology To Treat Rare Conditions Associated With Coenzyme-Q10 (Ubiquinone) Deficiencies
16 sept. 2021 09h05 HE | Clarus Therapeutics Holdings, Inc.
Agreement to accelerate development of potential treatments for rare, endocrine, metabolic, and neurological conditions associated with primary and secondary ubiquinone deficiencies which belong to...
General-Fusion-Image
Alliance grant for McGill Professor and Canadian fusion energy company
20 janv. 2021 09h00 HE | General Fusion; McGill University
Three-year project funded in part by Natural Science and Engineering Research Council (NSERC) will help Canadian company demonstrate fusion energy in a commercially relevant environment, paving the...
American Lithium Logo 721.jpg
American Lithium Process Testing Produces Lithium Carbonate From Claystone At TLC
10 sept. 2020 09h00 HE | American Lithium Corp.
VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- American Lithium Corp. (TSXV: LI) (OTCQB: LIACF) (Frankfurt: 5LA1) (“American Lithium” or the “Company”) a leading lithium exploration...